Site Reference ID/Investigator# 25024 — Encino, California

Site Reference ID/Investigator# 25024 is a clinical research site located in Encino, California, United States 91436.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 25024 has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer.

Sponsors: AbbVie (prior sponsor, Abbott).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Encino

Browse all research sites in California · View every site in Encino

• The University of California, Los Angeles
• Encino Hospital Medical Center
• The Retina Partners
• Pharmacology Research Institute
• Research Site
• Encino Research Center
• Novo Nordisk Investigational Site
• T Joseph Raoof Md Inc
• WR-PRI
• HRC Fertility
• Pfizer Investigational Site
• Clinical Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 25024?

Site Reference ID/Investigator# 25024 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 25024 conducted?

Site Reference ID/Investigator# 25024 has 1 clinical trials on record. Their work covers Ovarian Cancer.

Is Site Reference ID/Investigator# 25024 accredited by Crixeo Clinical Trials?

Site Reference ID/Investigator# 25024 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 25024?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.